Co-delivery of paclitaxel and cisplatin with biocompatible PLGA-PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models

5 years ago

Co-delivery of paclitaxel and cisplatin with biocompatible PLGA-PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models

Kyle Roche, Kin Man Au, Yuanzeng Min, Andrew Z. Wang, Zachary Rodgers, Kyle Wagner, C. Tilden Hagan, Jing Tian, Feifei Yang, Maofan Zhang

Nanoparticles co-loaded with paclitaxel and cisplatin potently enhance chemoradiotherapy in non-small cell lung cancer models versus the conventional free drug combination by delivering a precise therapeutic ratio.

Publisher URL: http://pubs.rsc.org/en/Content/ArticleLanding/2017/TB/C7TB01370A

DOI: 2017/TB/C7TB01370A

You might also like

Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.